News & Events
Latest News
Events
PrecisionLife identified as leaders in fight against COVID-19 by Barclays Private Bank
PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Prviate Bank. In an article published in September 2020, our unique technology platforms were highlighted, following our discovery of 68 genes that could be responsible...
Simon Beaulah joins PrecisionLife as SVP of Healthcare & Head of US Operations
PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment demonstrates the company’s focus on developing the US market and its commercial profile within the healthcare and precision medicine fields. Simon brings with...
68 risk-associated genes identified from analysis of hospitalized COVID-19 patients suggesting opportunities for genomic biomarkers and new treatment options
PrecisionLife's unique AI platform has found 68 genes associated with risk of developing severe COVID-19 after analysis of the genomes of 929 patients from the UK Biobank who had a severe response to SARS-CoV-2. Prior to an effective and widely available vaccine,...
Shared sepsis / severe COVID-19 genetic risk factors with 59 potential drug re-purposing candidates identified in fight against COVID-19
Using PrecisionLife's proprietary AI enabled precision medicine platform we have identified 59 re-purposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from...
Tackling Coronavirus with Digital Technologies – Virtual Conference and Networking Event, Wednesday 8th April, 2020, from 2pm
PrecisionLife CEO & Founder Dr Steve Gardner will be taking part in an expert panel discussion at a Virtual Conference and Networking Event looking at ‘Digital Medicine Solutions for COVID-19’ on Wednesday April 8th at 2pm. Organised by the International Society...